Nagendran Sukumar bought TSHA

September 10, 2025 · Form 4 insider transaction

Nagendran Sukumar bought 41,150 shares of Taysha Gene Therapies, Inc. at $0.70 per share, a transaction worth $28.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.